Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)

NCT02378480 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

655

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Infections
Skin Structures and Soft Tissue Infections

Interventions

DRUG: Omadacycline
DRUG: Linezolid

Sponsor

Paratek Pharmaceuticals Inc